Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Rapid Communication: Key changes to the treatment of drug-resistant tuberculosis

Report
Rapid Communication: Key changes to the treatment of drug-resistant tuberculosis

This document informs national TB programs and stakeholders about the key implications for the treatment of drug-resistant tuberculosis. This resource is available before the release of the updated guidelines in order for planning at the country level. The guidelines are expected to be released in 2020.

Author:

World Health Organization (WHO)

Audiences:

Physicians, International Agencies

Topic:

Extensively Drug-Resistant TB (XDR TB), MDR TB, TB Treatment, Treatment Guidelines Materials

Country of Origin:

Switzerland

Download PDF

Related Materials

Rapid Communication: Molecular assays as initial tests for the diagnosis of tuberculosis and rifampicin resistance

This material aims to inform national TB Programmes and other stakeholders about the key implications of the latest evidence on the use of specific molecular assays as initial diagnostic tests of pulmonary and extrapulmonary TB and RR-TB, in adults and children.

Report

Treatment of Drug-Resistant Tuberculosis

This fact sheet discusses treatment of drug-resistant TB. A table outlining potential drug regimens for treating drug-resistant TB is also provided.

Fact Sheet

An Activist’s Guide to Treatment for Drug-Resistant Tuberculosis

This guide details 2020 updates to the WHO guidelines about the global standard of care for drug-resistant TB. The guide also includes messaging and strategies that can be used to advocate for WHO-recommended regimens.

Book

Global resources for the prevention,
management, and elimination of TB.